Titan Pharmaceuticals (TTNP) Institutional Ownership $4.80 -0.07 (-1.33%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Titan Pharmaceuticals (NASDAQ:TTNP)CurrentInstitutional OwnershipPercentage31.49%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$44.78KNumber ofInstitutional Sellers(last 12 months)0 Get TTNP Insider Trade Alerts Want to know when executives and insiders are buying or selling Titan Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TTNP Institutional Buying and Selling by Quarter Titan Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/19/2025 Marex Group plc10,663$45K0.0%N/A1.172% 11/7/2022 Virtu Financial LLC28,331$31K0.0%-54.5%0.194% 10/26/2022 Truist Financial Corp625,089$675K0.0%N/A4.273% 10/19/2022 FNY Investment Advisers LLC28,025$30K0.0%N/A0.192% 9/17/2021 Virtu Financial LLC33,309$87K0.0%N/A0.338% 8/13/2021 Geode Capital Management LLC53,097$138K0.0%+49.5%0.538% 8/13/2021 Vanguard Group Inc.204,324$531K0.0%+180.7%2.071% 5/18/2021 Millennium Management LLC16,882$50K0.0%N/A0.171% (Data available from 1/1/2016 forward) TTNP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TTNP shares? During the previous two years, the following institutional investors and hedge funds held shares of Titan Pharmaceuticals shares: Marex Group plc ($45K).Learn more on Titan Pharmaceuticals' institutional investors. What percentage of Titan Pharmaceuticals' stock is owned by institutional investors? 31.49% of Titan Pharmaceuticals' stock is owned by institutional investors. Learn more on TTNP's institutional investor holdings. Which institutional investors have been buying Titan Pharmaceuticals' stock? The following institutional investors have purchased Titan Pharmaceuticals' stock in the last 24 months: Marex Group plc ($10.66K). How much institutional buying is happening at Titan Pharmaceuticals? Institutional investors have bought a total of 10,663 shares in the last 24 months. This purchase volume represents approximately $44.78K in transactions. Related Companies Aspire Biopharma Major Shareholders Chemomab Therapeutics Major Shareholders Synlogic Major Shareholders Mannatech Major Shareholders Pulmatrix Major Shareholders Hoth Therapeutics Major Shareholders X4 Pharmaceuticals Major Shareholders Lipocine Major Shareholders Lixte Biotechnology Major Shareholders NeuroSense Therapeutics Major Shareholders This page (NASDAQ:TTNP) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Titan Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Titan Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access